Zomedica Corp. (ZOMDF) Earnings Call Transcripts
Zomedica Corp.'s Latest Earnings Call - June 10, 2026
In the Q2 2026 earnings call for Zomedica Corp., management reported significant developments that could impact the stock. The company faced a setback as the advisory vote on executive compensation was not approved, with 129 million shares against it. Additionally, while the appointment of Grant Thornton LLP as the accountants for 2026 was ratified, the overall sentiment from the call suggests investor concerns about executive pay and governance could weigh on the stock in the near term.
Reported metrics
| Metric | Value |
|---|---|
| Votes for Executive Compensation | 99,891,971 (miss) |
| Votes for Appointment of Accountants | 403,285,558 (beat) |
| Votes for Bylaw Amendments | 123,410,315 (beat) |
| Votes for Director Elections | 429,583,699 (inline) |
What management said
It's Chris MacLeod. I move that the following individuals be elected as directors of Zomedica Corp. to serve 1-year terms expiring at the annual meeting in the year 2027 or upon the election and qualification of their successors. Those individuals are Jeffrey Rowe, Robert Cohen, Chris MacLeod, Dr. Pam Nichols, Johnny Powers, Sean Whelan, Rodney Williams, and Larry Heaton.
The second item of business is the ratification of the appointment of Grant Thornton LLP as the company's independent registered public accounting firm for 2026. I would accept a motion to ratify Grant Thornton LLP as our accountants.
What analysts pressed on
Analysts expressed concerns regarding the rejection of the executive compensation package, which could indicate broader issues with governance and shareholder relations. There is also apprehension about the implications of the failed vote on future management decisions and investor sentiment.
Main topics on the call
- Executive Compensation Vote — The advisory vote on executive compensation was not approved, with 129,290,109 shares voting against it. This outcome indicates shareholder dissatisfaction with executive pay structures, which could lead to increased scr...
- Appointment of Accountants — The appointment of Grant Thornton LLP as the independent registered public accounting firm for 2026 was ratified with 403,285,558 shares in favor. This reflects shareholder confidence in the company's financial oversight...
- Bylaw Amendments — Shareholders approved an amendment to the bylaws regarding quorum requirements for adjourned meetings, with 123,410,315 votes in favor. This change is expected to streamline future shareholder meetings and enhance govern...
- Director Elections — All eight nominated directors were elected to serve one-year terms expiring in 2027, indicating stable leadership. The election results suggest shareholder support for the current board.
Read the full Zomedica Corp. transcript (June 10, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.
About Zomedica Corp.
Zomedica Corp. (ZOMDF) is a publicly listed company in the Health Care Equipment and Supplies industry, within the Health Care sector. It trades on OTCPK and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 28 calls on record spanning September 25, 2020 to July 24, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 28 Zomedica Corp. earnings call transcripts on record, spanning September 25, 2020 to July 24, 2026. Based on this history, Zomedica Corp. reports quarterly. The most recent call on file is dated July 24, 2026. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- ZOMDF
- Exchange
- OTCPK
- Country
- US
- Sector
- Health Care
- Calls on record
- 28
- First call
- September 25, 2020
- Most recent
- July 24, 2026
- Reporting cadence
- quarterly